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Introduction
Acinar cell carcinoma (ACC) of the pancreas represents a
rare but distinctive clinicopathological entity [1,2], account-
ing for 1% of pancreatic exocrine malignant tumours [3,4]. It
derives mainly from transformed acinar cells [5], but an
endocrine component of the tumour may vary from a few
scattered cells to more than 25% of the neoplasm; such
tumours have been termed ‘mixed acinar-endocrine carci-
noma’ [6]. We report three patients with ACC, one with
mixed acinar-endocrine carcinoma, and review the clinical,
diagnostic and pathological features of these tumours.
Case report
Case no. 1
A 72-year-old man presented in March 1997 with an acute
onset of painless obstructive jaundice. Endoscopic retro-
grade cholangiopancreatography (ERCP) demonstrated an
irregular stricture 2 cm long in the lower common bile duct
(CBD), and a stent was placed to relieve the jaundice
(Figure 1). CT scan showed a 5-cm mass in the head of
pancreas with loss of the fat plane suggesting possible
tumour infiltration. Visceral angiography showed a well-
circumscribed vascular lesion suggestive of duodenal
leiomyoma (Figure 1). He had been on long-term anticoagu-
lation since 1986 for recurrent deep vein thrombosis.
Case report
Acinar cell carcinoma of the pancreas with and
without endocrine differentiation
IT Virlos, IM Papazachariou and RCN Wiliamson
Department of Surgery, Hammersmith Hospital, London, UK
Background
Acinar cell carcinoma (ACC) is a rare pancreatic neo-
plasm, representing 1% of exocrine tumours and contain-
ing a variable endocrine component.Three recent cases of
ACC are reported.
Case outlines
A 72-year-old man with painless obstructive jaundice had a
5-cm mass in the head of pancreas resected by Whipple’s
operation; histopathological examination showed a typical
ACC. A 33-year-old man with weight loss and abnormal
liver function had a dilated biliary tree but no mass on
imaging. Pylorus-preserving pancreatoduodenectomy was
performed, and histology showed a mixed acinar-neuro-
endocrine tumour. A 56-year-old man with weight loss and
a palpable mass had a 15-cm mass in the distal body of
pancreas, which was resected en bloc with the spleen and
adherent stomach; it was a cystic ACC.
Results
Two patients are alive and free of disease at 30 months and
15 months, while the third patient with locally advanced
disease died of myocardial infarction at 9 weeks.
Discussion
Acinar structures are the hallmark of this neoplasm, which
carries a better survival rate than ductal cancer. Surgical
excision prolongs survival and offers the best chance of cure.
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Figure 1. Case no.1.Late phase coeliac arteriogram showing an obvious tumour
‘blush’ in the head of the pancreas and the adjacent endoscopic stent (arrow).
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Laparotomy revealed a large but localised tumour, and
pancreatoduodenectomy was successfully carried out to in-
clude a distal gastrectomy. Histopathological examination
showed a typical ACC, and histochemistry was positive for
lipase.
Immunohistochemistry was strongly positive for a -1-
antitrypsin and a -1-antichymotrypsin and positive for
cytokeratin. It was negative for neurone specific enolase
(NSE) and chromogranin, but there was focal positivity for
synaptophysin (Table 1). The lymph nodes were free of
tumour. The patient remains well and free of overt disease
2 and a half years later.
Case no. 2
A 33-year-old man presented in November 1998 with a six-
week history of pruritus, 12 kg weight loss, alteration in
bowel habit and abnormal liver function tests: alkaline
phosphatase (ALP) 1448 UL21 (normal <115 UL21), ala-
nine aminotransferase (ALT) 197 UL21 (normal <40
UL21), c -glutamyltransferase ( c -GT) 1136 UL21 (normal
<50 UL21) but normal bilirubin. CT scan showed both
intra- and extrahepatic dilatation of the biliary tree, and
ERCP confirmed a low CBD stricture (Figure 2). A liver
biopsy raised the possible diagnosis of primary sclerosing
cholangitis, but the patient developed pain and a fall in
haemoglobin following the biopsy. With conservative treat-
ment for probable intraperitoneal bleeding his symptoms
gradually settled.
Since primary sclerosing cholangitis was an unconvinc-
ing explanation for the biliary stricture, the patient was
referred to this Unit where laparotomy revealed an
indurated mass in the lower head of the pancreas with no
evidence of metastasis. Routine pylorus-preserving proxi-
mal pancreatoduodenectomy (PPPP) was performed.
Histology showed a high-grade, malignant, mixed
acinar/neuroendocrine carcinoma of the head of pancreas
(3.5 cm in diameter). Some of the larger cells with a diffuse
cytokeratin pattern were strongly positive for lysozyme and
a -1 antitrypsin, representing the acinar part of the tumour.
The smaller cells stained positively for chromogranin, rep-
resenting the neuroendocrine part of the tumour (Table 1).
Final diagnosis was confirmed by electron microscopy.
Local excision was complete and there was no nodal
involvement, but extensive venous invasion was present. It
was decided to withhold adjuvant oncological treatment
since the resection appeared complete, and the patient
remains well 15 months later.
Case no. 3
A 56-year-old man presented in May 1996 with a cere-
brovascular accident (CVA) causing right hemiparesis and
aphasia. There was a history of myocardial infarction and
diabetes, and his mother had died of pancreatic cancer. He
also reported recent anorexia and 6 kg weight loss. A large
mass was palpable in the left upper quadrant, and CT
showed a 10 cm mass with central cavitation replacing the
distal body and tail of pancreas. In addition there was a
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Table 1. Immunohistochemical examination of ACC
Case no: 1 2 3
Lipase 11 2 2
a-1-antitrypsin 111 111 2
a-1-antichymotrypsin 111 2 1
Cytokeratin 11 11 111
Lysozyme 2 111 1
NSE 2 11 2
Chromogranin 2 11 1
Synaptophysin 1 2 2
CEA 2 2 1 Figure 2. Case no. 2. Endoscopic retrograde cholangiogram showing a low
common bile duct stricture.
15-mm low-density lesion in the spleen and a 4-mm diam-
eter low-density lesion in the right lobe of the liver. CT-
guided biopsy of the primary tumour showed poorly differ-
entiated pancreatic adenocarcinoma. A 24-hr urinary level
of adrenaline of 523 g (normal < 190 g/24 hr) suggested
a possible neuroendocrine origin of the tumour.
Angiography showed splenic vein thrombosis. Following an
episode of upper gastrointestinal bleeding, endoscopy was
performed to exclude ulceration of the tumour into the
stomach.
Laparotomy revealed a massive tumour (15 cm in
diameter) of the left pancreas, which was resected en bloc
with the spleen and a portion of adherent stomach (greater
curve). There was a penetrating gastric ulcer into the
tumour cavity, which contained offensive material.
Pathological examination showed a large cystic tumour
with extensive haemorrhage and necrosis and the histolog-
ical pattern of ACC. Local excision was complete, but
vascular and neural invasion were present with direct
involvement of the stomach and splenic capsule.
Immunohistochemical staining was strongly positive for
cytokeratin and carcinoembrionic antigen (CEA) and
weakly positive for a -1-antichymotrypsin, lysozyme and
chromogranin (Table 1). Postoperatively he developed
septicaemia and adult respiratory distress syndrome. He
remained in the intensive therapy unit for 8 weeks and
required tracheostomy and then transcatheter embolisation
for a bleeding colonic lesion that was probably angiodys-
plastic. Eventually he returned to the surgical ward in good
health and eating normally. Discharge home was approach-
ing when he suffered a massive myocardial infarction, from
which he died 10 days later.
Discussion
Acinar cell carcinoma (ACC) accounts for 1% of pancre-
atic exocrine malignant tumours [3,4]. This malignancy
shows a male predilection with a peak age in the seventh
decade [1]. Most of these tumours arise from the head of the
pancreas (56%), followed by the tail (36%) and the body
(8%). In two of our patients the ACC was located in the
head, while the third was in the distal body and tail. The
symptoms of patients with ACC are usually non-specific,
for example the anorexia and weight loss seen in two of our
patients. Unlike ductal adenocarcinoma, ACC may not
cause jaundice even when the tumour is located in the head
of pancreas [1]. A specific syndrome of subcutaneous fat
necrosis, panniculitis, polyarthralgia and blood eosino-
philia [1,7,8] is encountered when lipase is secreted in
excess from the tumour. This syndrome was not manifested
by any of our patients.
Macroscopically these tumours are typically solid [1,9].
Other features of ACC include haemorrhage and necrosis
[1] (seen in two cases) and the very rare cystic variant
[10,11] (seen in the third). The microscopic appearance of
ACC is distinctive. Acinar structures are the hallmark of
this neoplasm under the light microscope. A glandular and
trabecular pattern has been described, as well as vascular
and perineural invasion. The identification of zymogen
granules is the most characteristic ultrastructural finding,
and fibrillary internal structures may be present within the
granules [1]. Klimstra and colleagues [1] consider cytological
uniformity to be a consistent feature of ACC. Nevertheless,
cytological pleomorphism can rarely occur [12].
Immunohistochemical positivity in ACC has been report-
ed mainly for trypsin, but also for chymotrypsin, lipase, a -1-
antitrypsin, cytokeratin, lysozyme and rarely for amylase
[1,2,5,13,14]. In addition, ACC can show positivity for var-
ious tumour markers such as alpha-fetoprotein [15], carci-
noembryonic antigen [15,16] and CA 19-9 [15].
It is usually a straightforward matter to differentiate
ACC from ductal adenocarcinoma. Macroscopic distin-
guishing features of ACC include circumscription, a fleshy
consistency and polypoid growth into the duodenum; zymo-
gen granules are seen but not the true dense desmoplastic
stroma of ductal carcinoma [1]. Since tumours exhibiting
both ductal and acinar features have been reported in man
[17,18] as well as in a transgenic animal model [19], anti-
bodies against pancreatic enzymes can be used to confirm an
acinar cell origin. This evidence implicates acinar cells in
the pathogenesis of ductal adenocarcinoma [19]. On the
other hand, ACC may resemble endocrine tumours mor-
phologically [20]; a minor endocrine component may be
detected immunohistochemically in up to 40% of cases (as
in case no. 2). Although the diagnosis can be reached
clinically, confirmation of ACC is based on immunohisto-
chemistry and electron microscopy, which demonstrate
pancreatic enzymes and zymogen granules [1,5].
Surgical resection (pancreatectomy) offers the only
chance of cure and prolongs survival [1,21,22]. The
resectability rate of ACC is 64% [1], much higher than that
of ductal adenocarcinoma (10–20%) [21,22]. Chemo-
therapy can be used either preoperatively (intra-arterially)
[23] to reduce the tumour size or as palliative treatment
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alone or in combination with radiotherapy [1]. When pres-
ent, metastases from ACC are usually limited to the liver
and lymph  nodes [1,7,24], but the spleen [3], lung [5,18]
and adrenal gland [18] are other potential sites. Only one of
our patients has had locally advanced disease with direct
invasion of the stomach and spleen. Although 1-year sur-
vival is just over 50%, ACC is a very aggressive tumour
with an overall 5-year survival rate (5.9%) [1] similar to
that of ductal adenocarcinoma (6.1%) [22]. Age above 60
years, symptoms of lipase secretion and size >10 cm are asso-
ciated with a shorter survival time [1]. Two of our patients
are still alive at  212 years and 1 year, but both had localised
and relatively small tumours. The third patient with a large
and invasive tumour (>15 cm) had a prolonged postopera-
tive course and died of myocardial infarction at 12 weeks.
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